Alterations of prodynorphin gene expression in the rat mesocorticolimbic system during heroin self-administration

Brain Research

Volumn 1255, Issue , 2009, Pages 113-121

  Solecki, Wojciech ^a   Ziolkowska, Barbara ^a   Krowka, Tomasz ^a   Gieryk, Agnieszka ^a   Filip, Malgorzata ^a   Przewlocki, Ryszard ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Addiction; Contingent self administration; Gene expression; Heroin; Limbic forebrain; Prodynorphin

Indexed keywords

DIAMORPHINE; MESSENGER RNA; PRODYNORPHIN; PROENKEPHALIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG USE; GENE EXPRESSION; HEROIN DEPENDENCE; IN SITU HYBRIDIZATION; LIMBIC SYSTEM; MALE; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYGDALA; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CONDITIONING, OPERANT; CORPUS STRIATUM; ENKEPHALINS; EXTINCTION, PSYCHOLOGICAL; GENE EXPRESSION; HEROIN; IN SITU HYBRIDIZATION; MALE; NUCLEUS ACCUMBENS; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT SCHEDULE; RNA, MESSENGER; SELF ADMINISTRATION; TIME FACTORS;

RATTUS;

EID: 58949096500     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.12.002     Document Type: Article

References (64)

1. Asan E. The catecholaminergic innervation of the rat amygdala. Adv. Anat. Embryol. Cell Biol. 142 (1998) 1-118
2. Bart G., Heilig M., LaForge K.S., Pollak L., Leal S.M., Ott J., and Kreek M.J. Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol. Psychiatry 9 (2004) 547-549
3. Bart G., Kreek M.J., Ott J., LaForge K.S., Proudnikov D., Pollak L., and Heilig M. Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology 30 (2005) 417-422
4. Basheer R., and Tempel A. Morphine-induced reciprocal alterations in G alpha s and opioid peptide mRNA levels in discrete brain regions. J. Neurosci. Res. 36 (1993) 551-557
5. Beardsley P.M., Howard J.L., Shelton K.L., and Carroll F.I. Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology (Berl) 183 (2005) 118-126
6. Cappendijk S.L., Hurd Y.L., Nylander I., van Ree J.M., and Terenius L. A heroin-, but not a cocaine-expecting, self-administration state preferentially alters endogenous brain peptides. Eur. J. Pharmacol. 365 (1999) 175-182
7. Carey A.N., Borozny K., Aldrich J.V., and McLaughlin J.P. Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn. Eur. J. Pharmacol. 569 (2007) 84-89
8. Chavkin C., James I.F., and Goldstein A. Dynorphin is a specific endogenous ligand of kappa opioid receptor. Science 215 (1982) 413-415
9. Civelli O., Douglass J., Goldstein A., and Herbert E. Sequence and expression of the rat prodynorphin gene. Proc. Natl. Acad. Sci. 82 (1985) 4291-4295
10. Daunais J.B., and McGinty J.F. Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse 18 (1994) 35-45
11. 2 dopamine receptor blockade on zif/268 and prodynorphin gene expression in rat forebrain following a short-term cocaine binge. Mol. Brain Res. 35 (1996) 237-248
12. Devine D.P., Leone P., Pocock D., and Wise R.A. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J. Pharmacol. Exp. Ther. 266 (1993) 1236-1246
13. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. 85 (1988) 5274-5278
14. Di Chiara G., and North R.A. Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13 (1992) 185-193
15. Drakenberg K., Nikoshkov A., Horváth M.C., Fagergren P., Gharibyan A., Saarelainen K., Rahman S., Nylander I., Bakalkin G., Rajs J., Keller E., and Hurd Y.L. Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7883-7888
16. Fattore L., Cossu G., Spano M.S., Deiana S., Fadda P., Scherma M., and Fratta W. Cannabinoids and reward: interactions with the opioid system. Crit. Rev. Neurobiol. 16 (2004) 147-158
17. Filip M., Frankowska M., Zaniewska M., Gołda A., Przegaliński E., and Vetulani J. Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats. Psychopharmacology 192 (2007) 17-26
18. Frenois F., Stinus L., Di Blasi F., Cador M., and Le Moine C. A specific limbic circuit underlies opiate withdrawal memories. J. Neurosci. 25 (2005) 1366-1374
19. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma Jr. F.J., and Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250 (1990) 1429-1432
20. Goeders N.E. Stress and cocaine addiction. J. Pharmacol. Exp. Ther. 301 (2002) 785-789
21. Gonzalez-Nicolini M.V., Berglind W., Cole K.S., Keogh C.L., and McGinty J.F. Local mu and delta opioid receptors regulate amphetamine-induced behavior and neuropeptide mRNA in the striatum. Neuroscience 121 (2003) 387-398
22. Goodman R.R., Houghten R.A., and Pasternak G.W. Autoradiography of [3H]beta-endorphin binding in brain. Brain Res. 288 (1983) 334-337
23. Heinrichs S.C. Behavioural consequences of altered corticotropin releasing factor activation in brain: a functionalist view of affective neuroscience. In: Steckler T., Kalin N.H., and Reul J.M. (Eds). Handbook of stress and the brain (2005), Elsevier, New York 155-177
24. Heimer L., Zahm D.S., Churchill L., Kalivas P.W., and Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 41 (1991) 89-125
25. Horner K.A., and Keefe K.A. Regulation of psychostimulant-induced preprodynorphin, c-fos and zif/268 messenger RNA expression in the rat dorsal striatum by mu opioid receptor blockade. Eur. J. Pharmacol. 532 (2006) 61-73
26. Hurd Y.L., Brown E.E., Finlay J.M., Fibiger H.C., and Gerfen C.R. Cocaine self-administration differentially alters mRNA expression of striatal peptides. Mol. Brain Res. 13 (1992) 165-170
27. Inturrisi C.E. Clinical pharmacology of opioids for pain. Clin. J. Pain. 18 (2002) 3-13
28. Jacobs E.H., Smit A.B., de Vries T.J., and Schoffelmeer A.N.M. Neuroadaptive effects of active versus passive drug administration in addiction research. Trends Pharmacol. Sci. 24 (2003) 566-573
29. Jacobsen K.X., Höistad M., Staines W.A., and Fuxe K. The distribution of dopamine D1 receptor and mu-opioid receptor 1 receptor immunoreactivities in the amygdala and interstitial nucleus of the posterior limb of the anterior commissure: relationships to tyrosine hydroxylase and opioid peptide terminal systems. Neuroscience 141 (2006) 2007-2018
30. Kieffer B.L., and Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66 (2002) 285-306
31. Koob G.F., and Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001) 97-129
32. Kreek M.J., and Koob G.F. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 51 (1998) 23-47
33. Lecca D., Valentini V., Cacciapaglia F., Acquas E., and Di Chiara G. Reciprocal effects of response contingent and noncontingent intravenous heroin on in vivo nucleus accumbens shell versus core dopamine in the rat: a repeated sampling microdialysis study. Psychopharmacology 194 (2007) 103-116
34. Marchant N.J., Densmore V.S., and Osborne P.B. Coexpression of prodynorphin and corticotrophin-releasing hormone in the rat central amygdala: evidence of two distinct endogenous opioid systems in the lateral division. J. Comp. Neurol. 20 (2007) 702-715
35. McFarland K., and Kalivas P.W. The circuitry mediating cocaine-induced reinstatement of drug-seeking behaviour. J. Neurosci. 21 (2001) 8655-8663
36. McLaughlin J.P., Marton-Popovici M., and Chavkin C. Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J. Neurosci. 23 (2003) 5674-5683
37. McLaughlin J.P., Li S., Valdez J., Chavkin T.A., and Chavkin C. Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system. Neuropsychopharmacology 31 (2006) 1241-1248
38. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat. Rev., Neurosci. 2 (2001) 119-128
39. Nikoshkov A., Drakenberg K., Wang X., Horvath M.C., Keller E., and Hurd Y.L. Opioid neuropeptide genotypes in relation to heroin abuse: dopamine tone contributes to reversed mesolimbic proenkephalin expression. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 786-791
40. Nylander I., Vlaskovska M., and Terenius L. Brain dynorphin and enkephalin systems in Fischer and Lewis rats: effects of morphine tolerance and withdrawal. Brain Res. 68 (1995) 325-335
41. Nylander I., Vlaskovska M., and Terenius L. The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats. Psychopharmacology 118 (1995) 391-400
42. Oswald L.M., and Wand G.S. Opioids and alcoholism. Physiol. Behav. 81 (2004) 339-358
43. Petrovich G.D., and Swansons L.W. Projections from the lateral part of the central amygdalar nucleus to the postulated fear conditioning circuit. Brain Res. 763 (1997) 247-254
44. Pfeiffer A., Brantl V., Herz A., and Emrich H.M. Psychotomimesis mediated by kappa opiate receptors. Science 233 (1986) 774-776
45. Pontieri F.E., Tanda G., and Di Chiara G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. 92 (1995) 12304-12308
46. Reyes B.A., Drolet G., and Van Bockstaele E.J. Dynorphin and stress-related peptides in rat locus coeruleus: contribution of amygdalar efferents. J. Comp. Neurol. 508 (2008) 663-675
47. Rezayof A., Zarrindast M.R., Sahraei H., and Haeri-Rohani A.H. Involvement of dopamine D2 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat. Pharmacol. Biochem. Behav. 74 (2002) 187-197
48. Shippenberg T.S., and Herz A. Differential effects of mu and kappa opioid systems on motivational processes. NIDA Res. Monogr. 75 (1986) 563-566
49. Skoubis P.D., Lam H.A., Shoblock J., Narayanan S., and Maidment N.T. Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice. Eur. J. Neurosci. 21 (2005) 1379-1384
50. Spanagel R., Almeida O.F., Bartl C., and Shippenberg T.S. Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacology 115 (1994) 121-127
51. Spangler R., Zhou Y., Maggos C.E., Zlobin A., Ho A., and Kreek M.J. Dopamine antagonist and 'binge' cocaine effects on rat opioid and dopamine transporter mRNAs. NeuroReport 7 (1996) 2196-2200
52. Svingos A.L., Chavkin C., Colago E.E., and Pickel V.M. Major coexpression of kappa-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles. Synapse 42 (2001) 185-192
53. Tjon G.H., Voorn P., Vanderschuren L.J., de Vries T.J., Michiels N.H., Jonker A.J., Klop H., Nestby P., Mulder A.H., and Schoffelmeer A.N. Delayed occurrence of enhanced striatal preprodynorphin gene expression in behaviorally sensitized rats: differential long-term effects of intermittent and chronic morphine administration. Neuroscience 76 (1997) 167-176
54. Trujillo K.A., Bronstein D.M., Sanchez I.O., and Akil H. Effects of chronic opiate and opioid antagonist treatment on striatal opioid peptides. Brain Res. 698 (1995) 69-78
55. Turchan J., Lason W., Budziszewska B., and Przewlocka B. Effects of single and repeated morphine administration on the prodynorphin, proenkephalin and dopamine D2 receptor gene expression in the mouse brain. Neuropeptides 31 (1997) 24-28
56. Turchan J., Przewlocka B., Lason W., and Przewlocki R. Effects of repeated psychostimulant administration on the prodynorphin system activity and kappa opioid receptor density in the rat brain. Neuroscience 85 (1998) 1051-1059
57. Turchan J., Przewlocka B., Toth G., Lason W., Borsodi A., and Przewlocki R. The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat. Neuroscience 91 (1999) 971-977
58. Weissman B.A., and Zamir N. Differential effects of heroin on opioid levels in the rat brain. Eur. J. Pharmacol. 139 (1987) 121-123
59. Xi Z.X., Fuller S.A., and Stein E.A. Dopamine release in the nucleus accumbens during heroin self-administration is modulated by kappa opioid receptors: an in vivo fast-cyclic voltammetry study. J. Pharmacol. Exp. Ther. 284 (1998) 151-161
60. Yoshikawa K., Williams C., and Sabol S. Rat brain proenkephalin mRNA-cDNA cloning, primary structure, and distribution in the central nervous system. J. Biol. Chem. 259 (1984) 14301-14308
61. Young III W.S., Bonner T.I., and Brann M.R. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. Natl. Acad. Sci. 83 (1986) 9827-9831
62. Yukhananov R.Y., Zhai Q.Z., Persson S., Post C., and Nyberg F. Chronic administration of morphine decreases level of dynorphin A in the rat nucleus accumbens. Neuropharmacology 32 (1993) 703-709
63. Zhang F., Zhou W., Tang S., Lai M., Liu H., and Yang G. Motivation of heroin-seeking elicited by drug-associated cues is related to total amount of heroin exposure during self-administration in rats. Pharmacol. Biochem. Behav. 79 (2004) 291-298
64. Ziolkowska B., Stefanski R., Mierzejewski P., Zapart G., Kostowski W., and Przewlocki R. Contingency does not contribute to the effects of cocaine self-administration on prodynorphin and proenkephalin gene expression in the rat forebrain. Brain Res. 1069 (2006) 1-9